Skip to content

Contact +44 (0) 20 7060 7474 email us

OTC drugs

OTC Pharmaceuticals - Top 5 Emerging Markets Industry Guide

 

Publication Date September 2009
Publisher Datamonitor
Product Type Report
Pages 131
ISBN Number not applicable
Product Code DAT01790

Price

£655.00
approximately: $992 | €731

pdf

Buy Now

print £725 ($1,098 | €809)

Buy Now

Order above formats by FAX

Order by Fax

Summary

Datamonitor's OTC Pharmaceuticals - Top 5 Emerging Markets Industry Guide is an essential resource for top-level data and analysis covering the OTC Pharmaceuticals industry in each of the Top 5 Emerging markets (Brazil, China, India, Mexico and South Africa). The report includes easily comparable data on market value, volume, segmentation and market share, plus full five year market forecasts. It examines future problems, innovations and potential growth areas within the market.

Scope of the Report

  • Contains an executive summary and data on value, volume and segmentation
  • Provides textual analysis of the industry's prospects, competitive landscape and profiles of the leading companies
  • Incorporates in-depth five forces competitive environment analysis and scorecards
  • Compares data from Brazil, China, India, Mexico and South Africa, alongside individual chapters on each country. .
  • Includes a five-year forecast of the industry

Highlights

  • The Top 5 Emerging countries contributed $22.6 billion to the global OTC Pharmaceuticals industry in 2007, with a CAGR of 7.3% between 2004 and 2008
  • In 2013, the market is forecast to have a value of $32.5 billion, with a CAGR of 6.1% over the 2008-2013 period.
  • The Chinese OTC Pharmaceuticals industry is expected to lead the Top 5 emerging nations, with a value of $21.9 billion in 2013.

Why you should buy this report

  • Spot future trends and developments
  • Inform your business decisions
  • Add weight to presentations and marketing materials
  • Save time carrying out entry-level research

Market Definition

The OTC pharmaceuticals market values the total sales of traditional medicines, cough and cold preparations (tablets, mixtures, lozenges, topical remedies, inhalers), vitamins and minerals (multi-vitamins, single minerals, single vitamins, tonics), indigestion preparations (tablets, powders, mixtures), analgesics (Paracetamol, other analgesics, Ibuprofen, Aspirin), and other OTC healthcare products including; medicated skin products (anti-bacterials, acne treatments, anti-fungals, other medicated skin products, disinfectants), topical OTC medicines (anesthetic products, anti-itch products, antibiotic creams/gels), plasters & bandages (adhesive bandages/plasters, first aid tape, gauze pads/rolled gauze, other tape or bandage, liquid bandages), first aid kits and other OTC healthcare products (anti-smoking aids, rectal medications, eye/ear drops, sleeping aids, motion sickness) at retail selling price (RSP) and includes any applicable taxes.

Contents

  • Chapter 1 Introduction
    • 1.1 What Is This Report About?
    • 1.2 Who Is The Target Reader?
    • 1.3 How To Use This Report
    • 1.4 Definitions
  • Chapter 2 Top 5 Emerging Countries Otc Pharmaceuticals Industry Outlook
  • Chapter 3 Otc Pharmaceuticals In Brazil
    • 3.1 Market Overview
    • 3.2 Market Value
    • 3.3 Market Segmentation I
    • 3.4 Market Segmentation Ii
    • 3.5 Market Share
    • 3.6 Five Forces Analysis
    • 3.7 Leading Companies
    • 3.8 Distribution
    • 3.9 Market Forecasts
    • 3.10 Macroeconomic Indicators
  • Chapter 4 Otc Pharmaceuticals In China
    • 4.1 Market Overview
    • 4.2 Market Value
    • 4.3 Market Segmentation I
    • 4.4 Market Segmentation Ii
    • 4.5 Market Share
    • 4.6 Five Forces Analysis
    • 4.7 Leading Companies
    • 4.8 Distribution
    • 4.9 Market Forecasts
    • 4.10 Macroeconomic Indicators
  • Chapter 5 Otc Pharmaceuticals In India
    • 5.1 Market Overview
    • 5.2 Market Value
    • 5.3 Market Segmentation I
    • 5.4 Market Segmentation Ii
    • 5.5 Market Share
    • 5.6 Five Forces Analysis
    • 5.7 Leading Companies
    • 5.8 Distribution
    • 5.9 Market Forecasts
    • 5.10 Macroeconomic Indicators
  • Chapter 6 Otc Pharmaceuticals In Mexico
    • 6.1 Market Overview
    • 6.2 Market Value
    • 6.3 Market Segmentation I
    • 6.4 Market Segmentation Ii
    • 6.5 Market Share
    • 6.6 Five Forces Analysis
    • 6.7 Leading Companies
    • 6.8 Distribution
    • 6.9 Market Forecasts
    • 6.10 Macroeconomic Indicators
  • Chapter 7 Otc Pharmaceuticals In South Africa
    • 7.1 Market Overview
    • 7.2 Market Value
    • 7.3 Market Segmentation
    • 7.4 Market Share
    • 7.5 Five Forces Analysis
    • 7.6 Leading Companies
    • 7.7 Distribution
    • 7.8 Market Forecasts
    • 7.9 Macroeconomic Indicators
  • Chapter 8 Appendix
    • 8.1 Data Research Methodology
  • List Of Tables
    • Table 1: Top 5 Emerging Countries Otc Pharmaceuticals Industry, Revenue ($ Bn) 2004-2013
    • Table 2: Top 5 Emerging Countries Otc Pharmaceuticals Industry, Revenue ($Bn) 2004-2008(E)
    • Table 3: Top 5 Emerging Countries Otc Pharmaceuticals Industry Forecast, Revenue ($ Bn) 2008-2013
    • Table 4: Brazil Otc Pharmaceuticals Market Value: $ Billion, 2004-2008(E)
    • Table 5: Brazil Otc Pharmaceuticals Market Segmentation I: % Share, By Value, 2008(E)
    • Table 6: Brazil Otc Pharmaceuticals Market Segmentation Ii: % Share, By Value, 2008(E)
    • Table 7: Brazil Otc Pharmaceuticals Market Share: % Share, By Value, 2007
    • Table 8: Key Facts: Abbott Laboratories
    • Table 9: Key Facts: Novartis Ag
    • Table 10: Key Financials: Novartis Ag
    • Table 11: Key Facts: Glaxosmithkline Plc
    • Table 12: Key Financials: Glaxosmithkline Plc
    • Table 13: Brazil Otc Pharmaceuticals Distribution: % Share, By Value, 2008(E)
    • Table 14: Brazil Otc Pharmaceuticals Market Value Forecast: $ Billion, 2008-2013
    • Table 15: Brazil Size Of Population (Million) , 2004-2008(E)
    • Table 16: Brazil Gdp (Constant 2000 Prices, $ Billion), 2004-2008(E)
    • Table 17: Brazil Inflation, 2004-2008(E)
    • Table 18: Brazil Exchange Rate, 2004-2008(E)
    • Table 19: China Otc Pharmaceuticals Market Value: $ Billion, 2004- 2008(E)
    • Table 20: China Otc Pharmaceuticals Market Segmentation I: % Share, By Value, 2008(E)
    • Table 21: China Otc Pharmaceuticals Market Segmentation Ii: % Share, By Value, 2008(E)
    • Table 22: China Otc Pharmaceuticals Market Share: % Share, By Value, 2007
    • Table 23: Key Facts: Nin Jiom Medicine Manufactory Limited
    • Table 24: Key Facts: Huangshan Tianmu Pharmaceutical Co., Ltd
    • Table 25: Key Facts: Johnson & Johnson
    • Table 26: Key Financials: Johnson & Johnson
    • Table 27: China Otc Pharmaceuticals Distribution: % Share, By Value, 2008(E)
    • Table 28: China Otc Pharmaceuticals Market Value Forecast: $ Billion, 2008-2013
    • Table 29: China Size Of Population (Million) , 2004-2008(E)
    • Table 30: China Gdp (Constant 2000 Prices, $ Billion), 2004-2008(E)
    • Table 31: China Inflation, 2004-2008(E)
    • Table 32: China Exchange Rate, 2004-2008(E)
    • Table 33: India Otc Pharmaceuticals Market Value: $ Billion, 2004-2008(E)
    • Table 34: India Otc Pharmaceuticals Market Segmentation I: % Share, By Value, 2008(E)
    • Table 35: India Otc Pharmaceuticals Market Segmentation Ii: % Share, By Value, 2008(E)
    • Table 36: India Otc Pharmaceuticals Market Share: % Share, By Value, 2007
    • Table 37: Key Facts: Dabur India Limited
    • Table 38: Key Financials: Dabur India Limited
    • Table 39: Key Facts: Zandu Pharmaceutical Works Ltd
    • Table 40: Key Financials: Zandu Pharmaceutical Works Ltd
    • Table 41: Key Facts: Cipla Ltd
    • Table 42: Key Financials: Cipla Ltd
    • Table 43: India Otc Pharmaceuticals Distribution: % Share, By Value, 2008(E)
    • Table 44: India Otc Pharmaceuticals Market Value Forecast: $ Billion, 2008-2013
    • Table 45: India Size Of Population (Million) , 2004-2008(E)
    • Table 46: India Gdp (Constant 2000 Prices, $ Billion), 2004-2008(E)
    • Table 47: India Inflation, 2004-2008(E)
    • Table 48: India Exchange Rate, 2004-2008(E)
    • Table 49: Mexico Otc Pharmaceuticals Market Value: $ Billion, 2004- 2008(E)
    • Table 50: Mexico Otc Pharmaceuticals Market Segmentation I: % Share, By Value, 2008(E)
    • Table 51: Mexico Otc Pharmaceuticals Market Segmentation Ii: % Share, By Value, 2008(E)
    • Table 52: Mexico Otc Pharmaceuticals Market Share: % Share, By Value, 2007
    • Table 53: Key Facts: Boehringer Ingelheim Gmbh
    • Table 54: Key Financials: Boehringer Ingelheim Gmbh
    • Table 55: Key Facts: Pfizer Inc
    • Table 56: Key Financials: Pfizer Inc
    • Table 57: Key Facts: Bayer Ag
    • Table 58: Key Financials: Bayer Ag
    • Table 59: Mexico Otc Pharmaceuticals Distribution: % Share, By Value, 2008(E)
    • Table 60: Mexico Otc Pharmaceuticals Market Value Forecast: $ Billion, 2008-2013
    • Table 61: Mexico Size Of Population (Million) , 2004-2008(E)
    • Table 62: Mexico Gdp (Constant 2000 Prices, $ Billion), 2004-2008(E)
    • Table 63: Mexico Inflation, 2004-2008(E)
    • Table 64: Mexico Exchange Rate, 2004-2008(E)
    • Table 65: South Africa Otc Pharmaceuticals Market Value: $ Million, 2004-2008(E)
    • Table 66: South Africa Otc Pharmaceuticals Market Segmentation: % Share, By Value, 2008(E)
    • Table 67: South Africa Otc Pharmaceuticals Market Share: % Share, By Value, 2007
    • Table 68: Key Facts: Pfizer Inc
    • Table 69: Key Financials: Pfizer Inc
    • Table 70: Key Facts: Pharma Natura
    • Table 71: Key Facts: Weleda Group
    • Table 72: South Africa Otc Pharmaceuticals Distribution: % Share, By Value, 2008(E)
    • Table 73: South Africa Otc Pharmaceuticals Market Value Forecast: $ Million, 2008-2013
    • Table 74: South Africa Size Of Population (Million) , 2004-2008(E)
    • Table 75: South Africa Gdp (Constant 2000 Prices, $ Billion), 2004-2008(E)
    • Table 76: South Africa Inflation, 2004-2008(E)
    • Table 77: South Africa Exchange Rate, 2004-2008(E)
  • List Of Figures
    • Figure 1: Top 5 Emerging Countries Otc Pharmaceuticals Industry, Revenue ($ Bn) 2004-2013
    • Figure 2: Top 5 Emerging Countries Otc Pharmaceuticals Industry, Revenue ($ Bn) 2004-2008(E)
    • Figure 3: Top 5 Emerging Countries Otc Pharmaceuticals Industry Forecast, Revenue ($ Bn) 2008-2013
    • Figure 4: Brazil Otc Pharmaceuticals Market Value: $ Billion, 2004-2008(E)
    • Figure 5: Brazil Otc Pharmaceuticals Market Segmentation I: % Share, By Value, 2008(E)
    • Figure 6: Brazil Otc Pharmaceuticals Market Segmentation Ii: % Share, By Value, 2008(E)
    • Figure 7: Brazil Otc Pharmaceuticals Market Share: % Share, By Value, 2007
    • Figure 8: Forces Driving Competition In The Otc Pharmaceuticals Market In Brazil
    • Figure 9: Drivers Of Buyer Power In The Otc Pharmaceuticals Market In Brazil
    • Figure 10: Drivers Of Supplier Power In The Otc Pharmaceuticals Market In Brazil
    • Figure 11: Factors Influencing The Likelihood Of New Entrants In The Otc Pharmaceuticals Market In Brazil
    • Figure 12: Factors Influencing The Threat Of Substitutes In The Otc Pharmaceuticals Market In Brazil
    • Figure 13: Drivers Of Degree Of Rivalry In The Otc Pharmaceuticals Market In Brazil
    • Figure 14: Revenues & Profitability: Novartis Ag
    • Figure 15: Revenues & Profitability: Glaxosmithkline Plc
    • Figure 16: Brazil Otc Pharmaceuticals Distribution: % Share, By Value, 2008(E)
    • Figure 17: Brazil Otc Pharmaceuticals Market Value Forecast: $ Billion, 2008-2013
    • Figure 18: China Otc Pharmaceuticals Market Value: $ Billion, 2004- 2008(E)
    • Figure 19: China Otc Pharmaceuticals Market Segmentation I: % Share, By Value, 2008(E)
    • Figure 20: China Otc Pharmaceuticals Market Segmentation Ii: % Share, By Value, 2008(E)
    • Figure 21: China Otc Pharmaceuticals Market Share: % Share, By Value, 2007
    • Figure 22: Forces Driving Competition In The Otc Pharmaceuticals Market In China
    • Figure 23: Drivers Of Buyer Power In The Otc Pharmaceuticals Market In China
    • Figure 24: Drivers Of Supplier Power In The Otc Pharmaceuticals Market In China
    • Figure 25: Factors Influencing The Likelihood Of New Entrants In The Otc Pharmaceuticals Market In China
    • Figure 26: Factors Influencing The Threat Of Substitutes In The Otc Pharmaceuticals Market In China
    • Figure 27: Drivers Of Degree Of Rivalry In The Otc Pharmaceuticals Market In China
    • Figure 28: Revenues & Profitability: Johnson & Johnson
    • Figure 29: China Otc Pharmaceuticals Distribution: % Share, By Value, 2008(E)
    • Figure 30: China Otc Pharmaceuticals Market Value Forecast: $ Billion, 2008-2013
    • Figure 31: India Otc Pharmaceuticals Market Value: $ Billion, 2004-2008(E)
    • Figure 32: India Otc Pharmaceuticals Market Segmentation I: % Share, By Value, 2008(E)
    • Figure 33: India Otc Pharmaceuticals Market Segmentation Ii: % Share, By Value, 2008(E)
    • Figure 34: India Otc Pharmaceuticals Market Share: % Share, By Value, 2007
    • Figure 35: Forces Driving Competition In The Otc Pharmaceuticals Market In India
    • Figure 36: Drivers Of Buyer Power In The Otc Pharmaceuticals Market In India
    • Figure 37: Drivers Of Supplier Power In The Otc Pharmaceuticals Market In India
    • Figure 38: Factors Influencing The Likelihood Of New Entrants In The Otc Pharmaceuticals Market In India
    • Figure 39: Factors Influencing The Threat Of Substitutes In The Otc Pharmaceuticals Market In India
    • Figure 40: Drivers Of Degree Of Rivalry In The Otc Pharmaceuticals Market In India
    • Figure 41: Revenues & Profitability: Dabur India Limited
    • Figure 42: Revenues & Profitability: Zandu Pharmaceutical Works Ltd
    • Figure 43: Revenues & Profitability: Cipla Ltd
    • Figure 44: India Otc Pharmaceuticals Distribution: % Share, By Value, 2008(E)
    • Figure 45: India Otc Pharmaceuticals Market Value Forecast: $ Billion, 2008-2013
    • Figure 46: Mexico Otc Pharmaceuticals Market Value: $ Billion, 2004- 2008(E)
    • Figure 47: Mexico Otc Pharmaceuticals Market Segmentation I: % Share, By Value, 2008(E)
    • Figure 48: Mexico Otc Pharmaceuticals Market Segmentation Ii: % Share, By Value, 2008(E)
    • Figure 49: Mexico Otc Pharmaceuticals Market Share: % Share, By Value, 2007
    • Figure 50: Forces Driving Competition In The Otc Pharmaceuticals Market In Mexico
    • Figure 51: Drivers Of Buyer Power In The Otc Pharmaceuticals Market In Mexico
    • Figure 52: Drivers Of Supplier Power In The Otc Pharmaceuticals Market In Mexico
    • Figure 53: Factors Influencing The Likelihood Of New Entrants In The Otc Pharmaceuticals Market In Mexico
    • Figure 54: Factors Influencing The Threat Of Substitutes In The Otc Pharmaceuticals Market In Mexico
    • Figure 55: Drivers Of Degree Of Rivalry In The Otc Pharmaceuticals Market In Mexico
    • Figure 56: Revenues & Profitability: Boehringer Ingelheim Gmbh
    • Figure 57: Revenues & Profitability: Pfizer Inc
    • Figure 58: Revenues & Profitability: Bayer Ag
    • Figure 59: Mexico Otc Pharmaceuticals Distribution: % Share, By Value, 2008(E)
    • Figure 60: Mexico Otc Pharmaceuticals Market Value Forecast: $ Billion, 2008-2013
    • Figure 61: South Africa Otc Pharmaceuticals Market Value: $ Million, 2004-2008(E)
    • Figure 62: South Africa Otc Pharmaceuticals Market Segmentation: % Share, By Value, 2008(E)
    • Figure 63: South Africa Otc Pharmaceuticals Market Share: % Share, By Value, 2007
    • Figure 64: Forces Driving Competition In The Otc Pharmaceuticals Market In South Africa
    • Figure 65: Drivers Of Buyer Power In The Otc Pharmaceuticals Market In South Africa
    • Figure 66: Drivers Of Supplier Power In The Otc Pharmaceuticals Market In South Africa
    • Figure 67: Factors Influencing The Likelihood Of New Entrants In The Otc Pharmaceuticals Market In South Africa
    • Figure 68: Factors Influencing The Threat Of Substitutes In The Otc Pharmaceuticals Market In South Africa
    • Figure 69: Drivers Of Degree Of Rivalry In The Otc Pharmaceuticals Market In South Africa
    • Figure 70: Revenues & Profitability: Pfizer Inc
    • Figure 71: South Africa Otc Pharmaceuticals Distribution: % Share, By Value, 2008(E)
    • Figure 72: South Africa Otc Pharmaceuticals Market Value Forecast: $ Million, 2008-2013